Simponi 100 MG per 1 ML Auto-Injector
- RxCUI
- 1653166
- RxNorm name
- Simponi 100 MG per 1 ML Auto-Injector
- Display name
- Simponi 100 MG per 1 ML Auto-Injector
- Full name
- Simponi 100 MG per 1 ML Auto-Injector
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 125289 | Simponi | golimumab | 351(a) | Rx | 2026-09-01 |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f86cb4a7-c358-4136-ae57-b32bda9bba00 | Simponi 100 MG in 1 ML Auto-Injector [PSN] · 1 ML golimumab 100 MG/ML Auto-Injector [Simponi] [SBD] · 1 ML Simponi 100 MG/ML Auto-Injector [SY] · Simponi 100 MG per 1 ML Auto-Injector [SY] | 4 | 42 | These highlights do not include all the information needed to use SIMPONI safely and effectively. See full prescribing information for SIMPONI. SIMPONI ® (golimumab) injection, for subcutaneous use Initial U.S. Approval: 2009 | 20251029 |